Dermatology

Internalized skin bias also appeared to mediate the associations of depression and anxiety related to health-related quality of life.

An analysis of the EUROSTAD study found that the median duration of treatment with the biologic was 14 months.

The FDA asked the company to submit additional confirmatory evidence of effectiveness in the treatment of epidermolysis bullosa.

Investigators examined data on abrocitinib from the JADE REGIMEN study.

Itch intensity was highest at bedtime compared to all other time periods of the day.

Patients with allergic asthma could often have no clinical history of atopic dermatitis.

The most common burden of disease were itching, dry or rough skin, and cracked skin.

Those who were breastfed for less than 4 months also had lower risks of developing atopic diseases.

the high prevalence of the condition in middle-age and elderly populations has led to frequent updates on the long-term efficacy of current therapies and new investigational agents.

Telemedicine use has become more prevalent during the ongoing COVID-19 pandemic. However, there is limited data on patient satisfaction with tele-dermatology

Prior to the ISS, there was no known scale to measure ichthyosis severity across the entire body.

Dr. Chovatiya returns to speak of some of the changes regarding the study of skin of color that have occurred in recent years.

Experts explain the societal, systemic, and clinical challenges that come with managing skin disease in people of color.

Practice separation is occurring more frequently in medium- and large-sized practice groups and among early- and late-career dermatologists.

Dr. Bagel details newer topical therapies such as tapinarof and roflumilast, and speaks to how greater access to these therapies is needed among psoriasis patients.

Despite being the fastest growing racial group in the United States, Asian Americans have remained underrepresented in health disparities research.

Investigators observed that many patients with psoriasis are not actively seeing a primary care physician and would welcome management of their cardiovascular risk factors.

Mark Lebwohl, MD, and Jerry Bagel, MD, MS, review the currently available TNF-α and IL-12/23 inhibitors used to treat plaque psoriasis.

Spearheaded by Dr Bagel, the panel explores the role of phototherapy in the treatment of plaque psoriasis.

Recovery was often deemed rapid, with patients reporting post-surgical pain to be less severe than the pain of their disease.

Both PEARL 1 and PEARL 2 enrolled over 2000 adults and adolescents patients selected from 48 countries.

Prominent dermatologists detail how a biased literature, a lack of education, accessibility issues, and historical wrongdoings have all influenced the study of skin of color.

Investigators believe this could be a good option for patients who did not respond to a first-line biologic, though further research is required.

Investigators added that clinical condition at the time of vaccination and biologic treatment did not influence the humoral response in the enrolled patients.

Investigators suggest that improvements to care could be made based on experiences and recommendations from patients with chronic hand eczema.